Persistent Epstein-Barr virus DNA or its resurgence during treatment was associated with worse survival in patients with ...

Discover the facts about throat cancer symptoms, prevention tips, and breakthrough treatments giving patients new hope for ...

State of the Art: Personalizing Treatment for Patients With Metastatic Castration-Resistant Prostate Cancer Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer, where the endemic subtype ...

A sore throat or hoarseness that won’t improve could be more serious, according to Dr. Charles Johnson Jr., an ear, nose and throat (ENT) and head and neck surgeon. He ...

It is important to mention that patients in the Eastern studies ... HNC = Head and neck cancer; NPC = Nasopharyngeal cancer; NR = Not reported; NS = Not significant; RT = Radiation therapy ...

variants and nasopharyngeal carcinoma (NPC). NPC is a cancer notably prevalent in southern China, where it is 20 times more common than in non-endemic regions of the world. The findings ...

MONDAY, April 7, 2025 (HealthDay News) -- For patients with head and ... significant variation in incidence by cancer type, with the highest rate for nasopharyngeal carcinoma, followed by ocular ...

In animal trials, this combination resulted in a significant reduction in tumor size. The team then tested this therapy on six advanced nasopharyngeal cancer patients who had previously undergone ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

A key lung cancer congress held in Europe disclosed that a new breakthrough has been made by Hengrui Pharmaceuticals, a leading innovator in China’s pharmaceutical sector, to help prolong and improve ...

Incidence of RTOME is 5.83 percent in patients with head and neck cancer, with significant variation seen by cancer type.